Results 51 to 60 of about 151,581 (308)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Practice and Reflection on Scientific and Technological Strategic Intelligence [PDF]

open access: yesNongye tushu qingbao xuebao
[Purpose/Significance] The new round of technological revolution and industrial transformation is accelerating, and its impact on national development and security is becoming deeper and wider.
LENG Fuhai
doaj   +1 more source

Innovation management tools: implementing technology watch as a routine for adaptation

open access: yes, 2014
Innovation management (IM) is a multidisciplinary field which has been growing for the past few decades. However, the management of innovation is often considered equivalent to technology management or the management of research and development.
Zabala, Jon Mikel,, Lund University.
core   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Strategic technology management issues in Japanese manufacturing industry

open access: yes, 1989
The purpose of this paper is to elaborate upon some strategic technology management issues which have been identified in interviews with top technology managers in 14 major, technology-based Japanes corporations.
Alänge, Sverker,   +2 more
core  

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

open access: yesMolecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht   +3 more
wiley   +1 more source

Integrating halal tourism with sustainable development goals through Islamic values environmental responsibility and technological innovation

open access: yesDiscover Sustainability
This study examines the integration of halal tourism with global sustainability frameworks, particularly the United Nations Sustainable Development Goals (SDGs).
Nohman Khan   +4 more
doaj   +1 more source

Strategic technology management and the performance of firms in the electrical and electronics manufacturing industry of Malaysia (1986 - 1995) - An exploratory study

open access: yes, 2011
Malaysia has experienced robust economic growth since 1986. The manufacturing sector has been the main driving force behind this sustained and impressive performance.
Sikander, Arif
core  

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy